Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion type Assertion NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_head.
- NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion wasGeneratedBy ECO_0000203 NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_provenance.
- NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion wasDerivedFrom befree-20140225 NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_provenance.
- NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion SIO_000772 18285834 NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_provenance.
- NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion evidence source_evidence_literature NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_provenance.
- NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_provenance.